Psychosocial factors associated with adherence to antiretroviral medications in a sample of HIV-positive African American drug users

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 16, Issue 4, 2004, Pages 458-470

  Harzke, A J ^a,c   Williams, M L ^a   Nilsson Schonnesson L ^b   Ross, M W ^a   Timpson, S ^a   Keel, K B ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b STOCKHOLM SÖDER HOSPITAL   (Sweden)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AFFECT; AFRICAN AMERICAN; ANTIBIOTIC THERAPY; ARTICLE; COGNITION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ABUSE; DRUG DEPENDENCE; FEMALE; HEALTH BEHAVIOR; HEALTH CARE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; SELF REPORT; SOCIAL PSYCHOLOGY; SOCIAL SUPPORT;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ANTI-HIV AGENTS; ATTITUDE TO HEALTH; FEMALE; HUMANS; MALE; PATIENT COMPLIANCE; QUESTIONNAIRES; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 2442545145     PISSN: 09540121     EISSN: None     Source Type: Journal    
DOI: 10.1080/09540120410001683394     Document Type: Article

References (38)

1. ARNSTEN, J., DEMAS, P., FARZADEGAN, H., GRANT, R., GOUREVITCH, M., CHANG, C., BUONO, D., ECKHOLDT, H., HOWARD, A. & SCHOENBAUM, E. (2001). Antiretroviral adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring. Clinical Infectious Diseases, 33, 1417-1423.
2. AVANTS, S., MARGOLIN, A., WARBURTON, L., HAWKINS, K. & SHI, J. (2001). Predictors of non-adherence to HIV-related medication regimens during methadone stabilization. American Journal of Addiction, 10, 69-78.
3. BARTLETT, J. (2002). Addressing the challenges of adherence. Journal of Acquired Immune Deficiency Syndromes, 29, S2-S10.
4. BLACKWELL, B. (1996). From compliance to alliance: a quarter century of research. Netherlands Journal of Medicine, 48, 140-149.
5. BROERS, B., MORABIA, A. & HIRSCHEL, B. (1994). A cohort study of drug users' compliance with zidovudine treatments. Archives of Internal Medicine, 154, 1121-1127.
6. CHEEVER, L. & WU, A. (1999). Medication adherence among HIV-infected patients: understanding the complex behavior of patients taking this complex therapy. Current Infectious Disease Reports, 1, 401-407.
7. CHESNEY, M. (2000). Factors affecting adherence to antiretroviral therapy. Clinical Infectious Diseases, 30, S171-S176.
8. CHESNEY, M., ICKOVICS, J., CHAMBERS, D., GIFFORD, A., NEIDIG, J., ZWICKL, B. & WU, A. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group. AIDS Care, 12, 255-266.
9. ELDRED, L., WU, A., CHAISSON, R. & MOORE, R (1998). Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease. Acquired Journal of Immune Deficiency Syndrome and Human Retrovirology, 18, 117-125.
10. FERRANDO, S., WALL, T., BAKTI, S. & SORENSON, J. (1996). Psychiatric morbidity, illicit drug use and adherence to zidovudine (AZT) among injection users with HIV disease. American Journal of Drug and Alcohol Abuse, 22, 475-487.
11. FRAZIER, P., DAVIS-ALI, S. & DAHL, K. (1994). Correlates of noncompliance among renal transplant recipients. Clinical Transplantation, 8, 550-557.
12. GIFFORD, A., BORMAN, J., SHIVELY, M., WRIGHT, B., RICHMAN, D & BOZETTE, S. (2000). Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. Journal of Acquired Immune Deficiency Syndrome, 23, 386-395.
13. GLANZ, K., LEWIS, F. & RIMER, B. (1997). Health behavior and health education. San Francisco, CA: Jossey-Bass.
14. GOLIN, C., LIU, H., HAYS, R., MILLER, L.G., BECK, C., ICKOVICS, J., KAPLAN, A. & WENGER, N. (2002). A prospective study of adherence to antiretroviral medication. Journal of General Internal Medicine, 17 (10), 756-765.
15. GORDILLO, V., DEL AMO, J., SORIANO, V. & GONZALEZ-LAHOZ, J. (1999). Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS, 13, 1763-1769.
16. HAUBRICH, R., LITTLE, S., CURRIER, J. et al. (1999). The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group. AIDS, 13, 1099-1107.
17. JENSEN-FANGEL, S., PEDERSEN, L., LARSEN, C., TAURIS, P., MELLER, A., SERENSEN, H. & OBEL, N. (2002). The effect of race/ethnicity on the outcome of highly active antiretroviral therapy for human immunodeficiency virus type-1 patients. Clinical Infectious Diseases, 35, 1541-1548.
18. KALICHMAN, S. & ROMPA, D. (2000). Functional health literacy is associated with health status and health-related knowledge in people living with HIV-AIDS. Journal of Acquired Immune Deficiency Syndrome, 25, 337-344.
19. KALICHMAN, S., RAMACHANDRAN, B. & CATZ, S. (1999). Adherence to combination antiretroviral therapies in HIV-patients of low health literacy. Journal of General Internal Medicine, 14, 267-273.
20. KEMPPAINEN, J., LEVINE, R., MISTAL, M. & SCHMIDGALL, D. (2001). HAART adherence in culturally diverse patients with HIV/AIDS: a study of male patients from a Veteran's Administration Hospital in northern California. AIDS Patient Care and STDS, 15, 117-127.
21. KLEEBURGER, C., PHAIR, J., STRATHDEE, S., DETELS, R., KINGSLEY, L. & JACOBSON, L. (2001). Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the Multicenter AIDS Cohort Study. Journal of Acquired Immune Deficiency Syndromes, 26, 82-92.
22. LAZARUS, R. & FOLKMAN, S. (1984). Stress, appraisal, and coping. New York: Springer.
23. LIU, H., GOLIN, C., MILLER, L., HAYS, R., BECK, C., SANANDAJI, S., CHRISTIAN, J., MALDONADO, T., DURAN, D., KAPLAN, A. & WENGER, N. (2001). A comparison study of multiple measures of adherence to HIV protease inhibitors. Annals of Internal Medicine, 134, 968-977.
24. MOATTI, J., CARRIERI, M., SPIRE, B., GASTAUT, J., CASSUTO, J., MOREAU, J. & THE MANIF 2000 STUDY GROUP (2000). Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment. AIDS, 14, 151-155.
25. MUMA, R., ROSS, M., PARCEL, G. & POLLARD, R. (1995). Zidovudine adherence among individuals with HIV infection. AIDS Care, 7, 439-447.
26. NOEKER, M. & PETERMANN, F. (1998). Children's and adolescents' perception of their asthma bronchiale. Child: Care, Health and Development, 24, 21-30.
27. PEYROT, M., MCMURRY, J. & KRUGER, D. (1999). A biopsychosocial model of glycemic control in diabetes: stress, coping, and regimen adherence. Journal of Health and Social Behavior, 40, 141-158.
28. RABKIN, J. & CHESNEY, M. (1999). Treatment adherence to HIV medications: the Achilles' heel of the new therapies. In: OSTROW, D. & KALICHMAN, S. (Eds), Psychosocial and public health impacts of new HIV therapies (pp. 61-82). New York: Kluwer Academic/Plenum Publishers.
29. REID, G., DUBOW, E., CAREY, T. & DURA, J. (1994). Contribution of coping to medical adjustment and treatment responsibility among children and adolescents with diabetes. Developmental and Behavioral Pediatrics, 15, 327-335.
30. ROBERTS, K. (2000). Barriers and facilitators of HIV-positive patients' adherence to antiretroviral treatment regimens. AIDS Patient Care and STDS, 14, 155-168.
31. ROBERTS, K. & MANN, T (2000). Barriers to antiretroviral medication adherence in HIV-infected women. AIDS Care, 12 (4), 377-386.
32. SAMET, J., LIBMAN, H., STEGER, K., DHAWAN, R., CHEN, J., SHEVITZ, A., DEWEES-DUN, R., LEVENSON, S., KUFE, D. & CRAVEN, D. (1992). American Journal of Medicine, 92 (5), 495-502.
33. SINGH, N., BERMAN, S., SWINDELLS, S., JUSTIS, J., MOHR, J., SQUIER, C. & WAGENER, M. (1999). Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy. Clinical Infectious Disease, 29, 824-830.
34. SINGH, N., SQUIER, C., SIVEK, C., WAGENER, M., HONG NGUYEN, M. & YU, V. (1996). Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care, 8, 261-269.
35. STALL, R., HOFF, C., COATES, T., PAUL, J., PHILLIPS, K., EKSTRAND, M., KEGELES, S., CATANIA, J., DAIGLE, D. & DIAZ, R. (1996). Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 11 (2), 151-160.
36. WAGNER, G. & RABKIN, J. (2000). Measuring medication adherence: are missed doses reported more accurately than perfect adherence. AIDS Care, 12 (4), 405-408.
37. WEIDLE, P., GANEA, C., IRWIN, K., MCGOWAN, J., ERNST, J., OLIVO, N. & HOLMBERG, S. (1999). Adherence to antiretroviral medications in an inner-city population. Journal of Acquired Immune Deficiency Syndromes, 22, 498-502.
38. WILLIAMS, M., BOWEN, A., ROSS, M., FREEMAN, R. & ELWOOD, W (2000). Perceived compliance with AZT dosing among a sample of African-American drug users. International Journal of STD & AIDS, 11, 57-63.